Correlation Between Equillium and Aadi Bioscience
Can any of the company-specific risk be diversified away by investing in both Equillium and Aadi Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Aadi Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Aadi Bioscience, you can compare the effects of market volatilities on Equillium and Aadi Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Aadi Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Aadi Bioscience.
Diversification Opportunities for Equillium and Aadi Bioscience
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Equillium and Aadi is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Aadi Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aadi Bioscience and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Aadi Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aadi Bioscience has no effect on the direction of Equillium i.e., Equillium and Aadi Bioscience go up and down completely randomly.
Pair Corralation between Equillium and Aadi Bioscience
Allowing for the 90-day total investment horizon Equillium is expected to generate 1.42 times more return on investment than Aadi Bioscience. However, Equillium is 1.42 times more volatile than Aadi Bioscience. It trades about 0.03 of its potential returns per unit of risk. Aadi Bioscience is currently generating about -0.02 per unit of risk. If you would invest 84.00 in Equillium on September 12, 2024 and sell it today you would lose (14.00) from holding Equillium or give up 16.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Equillium vs. Aadi Bioscience
Performance |
Timeline |
Equillium |
Aadi Bioscience |
Equillium and Aadi Bioscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Equillium and Aadi Bioscience
The main advantage of trading using opposite Equillium and Aadi Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Aadi Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aadi Bioscience will offset losses from the drop in Aadi Bioscience's long position.Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Aadi Bioscience vs. Equillium | Aadi Bioscience vs. DiaMedica Therapeutics | Aadi Bioscience vs. Valneva SE ADR | Aadi Bioscience vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |